Arry Biopharma Soars 20% On Positive Phase 3 Melanoma Trial

Arry Biopharma soars 20% on positive phase 3 Melanoma trial.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.